The Efficacy and Toxicity of Neoadjuvant Chemotherapy Regimens of Epirubicin Plus Cyclophosphamide Followed by Docetaxel or Paclitaxel in Female Breast Cancer Patients

PURPOSE: To retrospectively analyze the efficacy and toxicity of epirubicin plus cyclophosphamide followed by docetaxel (EC-D) and epirubicin plus cyclophosphamide followed by paclitaxel (EC-P) efficacy as neoadjuvant chemotherapy regiments by pathological complete response (pCR) in this study. METH...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Manag Res
Main Authors: Wu, Xian, Ye, Chaoran, Wang, Xingmeng, Cai, Ruyu, Yang, Junzhe, Yu, Xiafei, Zhou, Yi, Shen, Li, Zhu, Yanhui, Liu, Xiaoan
Format: Artigo
Language:Inglês
Published: Dove 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7894818/
https://ncbi.nlm.nih.gov/pubmed/33623431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S284638
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items